Your browser doesn't support javascript.
loading
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
Noemia S Lima; Maryam Musayev; Timothy S Johnston; Danielle A Wagner; Amy R Henry; Lingshu Wang; Eun Sung Yang; Yi Zhang; Kevina Birungi; Walker P Black; Stephen D Schmidt; Cynthia G Lorang; Bingchun Zhao; Man Chen; Kristin L. Boswell; Jesmine Roberts-Torres; Rachel L Davis; Lowrey Peyton; Sandeep R Narpala; Jennifer Wang; Chloe Adrienna Talana; Kwanyee Leung; Wei Shi; Rawan Khashab; Asaf Biber; Tal Zilberman; Joshua Rhein; Sara Vetter; Afeefa Ahmed; Laura Novik; Alicia Widge; Ingelise Gordon; Mercy Guech; I-Ting Teng; Emily Phung; Tracy J. Ruckwardt; Amarendra Pegu; John Misasi; Nicole A Doria-Rose; Martin Gaudinski; Richard A Koup; Peter D Kwong; Adrian B McDermott; Sharon Amit; Timothy W Schacker; Itzchak Levy; John R Mascola; Nancy J Sullivan; Chaim A Schramm; Daniel C Douek.
Afiliação
  • Noemia S Lima; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Maryam Musayev; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Timothy S Johnston; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Danielle A Wagner; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Amy R Henry; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Lingshu Wang; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Eun Sung Yang; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Yi Zhang; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Kevina Birungi; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Walker P Black; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Stephen D Schmidt; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Cynthia G Lorang; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Bingchun Zhao; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Man Chen; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Kristin L. Boswell; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Jesmine Roberts-Torres; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Rachel L Davis; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Lowrey Peyton; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Sandeep R Narpala; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Jennifer Wang; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Chloe Adrienna Talana; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Kwanyee Leung; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Wei Shi; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Rawan Khashab; Sheba Medical Center
  • Asaf Biber; Sheba Medical Center & Tel Aviv University
  • Tal Zilberman; Sheba Medical Center & Tel Aviv University
  • Joshua Rhein; University of Minnesota
  • Sara Vetter; Minnesota Department of Health
  • Afeefa Ahmed; University of Minnesota
  • Laura Novik; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Alicia Widge; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Ingelise Gordon; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Mercy Guech; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • I-Ting Teng; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Emily Phung; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Tracy J. Ruckwardt; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Amarendra Pegu; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • John Misasi; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Nicole A Doria-Rose; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Martin Gaudinski; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Richard A Koup; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Peter D Kwong; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Adrian B McDermott; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Sharon Amit; Sheba Medical Center
  • Timothy W Schacker; University of Minnesota
  • Itzchak Levy; Sheba Medical Center & Tel Aviv University
  • John R Mascola; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Nancy J Sullivan; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Chaim A Schramm; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Daniel C Douek; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Preprint em En | PREPRINT-BIORXIV | ID: ppbiorxiv-486152
ABSTRACT
An important consequence of infection with a SARS-CoV-2 variant is protective humoral immunity against other variants. The basis for such cross-protection at the molecular level is incompletely understood. Here we characterized the repertoire and epitope specificity of antibodies elicited by Beta, Gamma and ancestral variant infection and assessed their cross-reactivity to these and the more recent Delta and Omicron variants. We developed a high-throughput approach to obtain immunoglobulin sequences and produce monoclonal antibodies for functional assessment from single B cells. Infection with any variant elicited similar cross-binding antibody responses exhibiting a remarkably conserved hierarchy of epitope immunodominance. Furthermore, convergent V gene usage and similar public B cell clones were elicited regardless of infecting variant. These convergent responses despite antigenic variation may represent a general immunological principle that accounts for the continued efficacy of vaccines based on a single ancestral variant.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Rct Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Rct Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
...